Given that the root cause of hematological malignancies resides within the malignant stem cell niche, its cellular and secretory components, including CXCL12, play critical roles in regulating the survival, proliferation, and anchorage of leukemia stem cells, thereby contributing to drug resistance and disease recurrence [6,7,8]. The gene discussed is CXCL12; the disease is hematologic disorder.